Heat treatment for cancer cleared by FDA:
This article was originally published in Clinica
Executive Summary
US company Biotechnology Control has received FDA clearance to market its ThermoChem-HT system. The procedure involves heating the peritoneum, which makes areas more receptive to therapies such as chemotherapy or natural biological agents. It is now recognised at the Wake Forest Medical Center North Carolina as standard-of-care for treatment of ovarian, gastrointestinal and other tumours that have disseminated to the lining surface of the abdomen and pelvis.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.